Mata-MarÃn, J.A.; Juárez-Contreras, C.A.; RodrÃguez-Evaristo, M.S.; MartÃnez-Carrizales, O.C.; Pompa-Mera, E.; Chaparro Sánchez, A.; Triana-González, S.; Cano-DÃaz, A.L.; Gaytán-MartÃnez, J.E.
Reversibility of Neuropsychiatric Adverse Events after Switching to Darunavir/Cobicistat or Doravirine in Men on INSTI-Based Regimen. Viruses 2024, 16, 1083.
https://doi.org/10.3390/v16071083
AMA Style
Mata-MarÃn JA, Juárez-Contreras CA, RodrÃguez-Evaristo MS, MartÃnez-Carrizales OC, Pompa-Mera E, Chaparro Sánchez A, Triana-González S, Cano-DÃaz AL, Gaytán-MartÃnez JE.
Reversibility of Neuropsychiatric Adverse Events after Switching to Darunavir/Cobicistat or Doravirine in Men on INSTI-Based Regimen. Viruses. 2024; 16(7):1083.
https://doi.org/10.3390/v16071083
Chicago/Turabian Style
Mata-MarÃn, José Antonio, Carina Aurora Juárez-Contreras, Mara Soraya RodrÃguez-Evaristo, Olivia Concepción MartÃnez-Carrizales, Ericka Pompa-Mera, Alberto Chaparro Sánchez, Salma Triana-González, Ana Luz Cano-DÃaz, and Jesús Enrique Gaytán-MartÃnez.
2024. "Reversibility of Neuropsychiatric Adverse Events after Switching to Darunavir/Cobicistat or Doravirine in Men on INSTI-Based Regimen" Viruses 16, no. 7: 1083.
https://doi.org/10.3390/v16071083
APA Style
Mata-MarÃn, J. A., Juárez-Contreras, C. A., RodrÃguez-Evaristo, M. S., MartÃnez-Carrizales, O. C., Pompa-Mera, E., Chaparro Sánchez, A., Triana-González, S., Cano-DÃaz, A. L., & Gaytán-MartÃnez, J. E.
(2024). Reversibility of Neuropsychiatric Adverse Events after Switching to Darunavir/Cobicistat or Doravirine in Men on INSTI-Based Regimen. Viruses, 16(7), 1083.
https://doi.org/10.3390/v16071083
